IPCA Laboratories Limited
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic t… Read more
IPCA Laboratories Limited (IPCALAB) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.088x
Based on the latest financial reports, IPCA Laboratories Limited (IPCALAB) has a cash flow conversion efficiency ratio of 0.088x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹7.80 Billion) by net assets (₹88.66 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
IPCA Laboratories Limited - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how IPCA Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
IPCA Laboratories Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of IPCA Laboratories Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SHREE CEMENT LIMITED
NSE:SHREECEM
|
0.219x |
|
Konecranes ABP
LSE:0MET
|
0.076x |
|
Galp Energa
PINK:GLPEY
|
0.146x |
|
Cembra Money Bank AG
PINK:CMBNF
|
0.116x |
|
Torex Gold Resources Inc
PINK:TORXF
|
0.039x |
|
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
|
0.047x |
|
PHARMARON BEIJING H YC1
F:17Q1
|
N/A |
|
S.P.E.E.H Hidroelectrica S.A.
RO:H2O
|
N/A |
Annual Cash Flow Conversion Efficiency for IPCA Laboratories Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of IPCA Laboratories Limited from 2005 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹83.88 Billion | ₹12.75 Billion | 0.152x | +24.34% |
| 2024-03-31 | ₹77.27 Billion | ₹9.45 Billion | 0.122x | -10.26% |
| 2023-03-31 | ₹59.15 Billion | ₹8.06 Billion | 0.136x | -11.81% |
| 2022-03-31 | ₹55.42 Billion | ₹8.56 Billion | 0.154x | -33.17% |
| 2021-03-31 | ₹47.16 Billion | ₹10.90 Billion | 0.231x | +49.15% |
| 2020-03-31 | ₹36.41 Billion | ₹5.64 Billion | 0.155x | -2.94% |
| 2019-03-31 | ₹31.38 Billion | ₹5.01 Billion | 0.160x | +25.84% |
| 2018-03-31 | ₹26.89 Billion | ₹3.41 Billion | 0.127x | +10.51% |
| 2017-03-31 | ₹24.55 Billion | ₹2.82 Billion | 0.115x | -63.40% |
| 2016-03-31 | ₹22.59 Billion | ₹7.09 Billion | 0.314x | +47.95% |
| 2015-03-31 | ₹22.08 Billion | ₹4.68 Billion | 0.212x | -20.45% |
| 2014-03-31 | ₹19.60 Billion | ₹5.22 Billion | 0.267x | +6.52% |
| 2013-03-31 | ₹15.54 Billion | ₹3.89 Billion | 0.250x | -11.33% |
| 2012-03-31 | ₹12.54 Billion | ₹3.54 Billion | 0.282x | +38.44% |
| 2011-03-31 | ₹10.51 Billion | ₹2.14 Billion | 0.204x | -7.90% |
| 2010-03-31 | ₹8.64 Billion | ₹1.91 Billion | 0.221x | -8.38% |
| 2009-03-31 | ₹6.31 Billion | ₹1.52 Billion | 0.242x | +34.29% |
| 2008-03-31 | ₹5.89 Billion | ₹1.06 Billion | 0.180x | -26.18% |
| 2007-03-31 | ₹4.74 Billion | ₹1.15 Billion | 0.244x | -25.52% |
| 2006-03-31 | ₹3.70 Billion | ₹1.21 Billion | 0.327x | +84.36% |
| 2005-03-31 | ₹3.26 Billion | ₹578.45 Million | 0.177x | -- |